Search

Home > WBUR News > Competitor's Record-Price Drug Could Add To Biogen's Challenges
Podcast: WBUR News
Episode:

Competitor's Record-Price Drug Could Add To Biogen's Challenges
Category: News & Politics
Duration: 00:02:38
Publish Date: 2019-05-14 09:18:50
Description: The FDA this month is expected to approve a new therapy that will compete with Spinraza, which generated $1.7 billion for Cambridge-based Biogen last year.
Total Play: 0

Some more Podcasts by WBUR

3K+ Episodes
Radio Boston     4
2K+ Episodes
On Point 3     10+
200+ Episodes
Kind World    
80+ Episodes
Last Seen 9     1